These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 20724726)
1. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates. Bratt O; Garmo H; Adolfsson J; Bill-Axelson A; Holmberg L; Lambe M; Stattin P J Natl Cancer Inst; 2010 Sep; 102(17):1336-43. PubMed ID: 20724726 [TBL] [Abstract][Full Text] [Related]
2. Familial prostate cancer in Sweden. A nationwide register cohort study. Grönberg H; Damber L; Damber JE Cancer; 1996 Jan; 77(1):138-43. PubMed ID: 8630920 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985 [TBL] [Abstract][Full Text] [Related]
4. PCBaSe Sweden: a register-based resource for prostate cancer research. Hagel E; Garmo H; Bill-Axelson A; Bratt O; Johansson JE; Adolfsson J; Lambe M; Stattin P Scand J Urol Nephrol; 2009; 43(5):342-9. PubMed ID: 19921977 [TBL] [Abstract][Full Text] [Related]
5. Age specific and attributable risks of familial prostate carcinoma from the family-cancer database. Hemminki K; Czene K Cancer; 2002 Sep; 95(6):1346-53. PubMed ID: 12216104 [TBL] [Abstract][Full Text] [Related]
6. Familial risk of cancer shortly after diagnosis of the first familial tumor. Bermejo JL; Hemminki K J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177 [TBL] [Abstract][Full Text] [Related]
7. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden. Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039 [TBL] [Abstract][Full Text] [Related]
8. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. Fang F; Keating NL; Mucci LA; Adami HO; Stampfer MJ; Valdimarsdóttir U; Fall K J Natl Cancer Inst; 2010 Mar; 102(5):307-14. PubMed ID: 20124521 [TBL] [Abstract][Full Text] [Related]
9. Population-based study of prostate-specific antigen testing and prostate cancer detection in clinical practice in northern Sweden. Pilebro B; Johansson R; Damber L; Damber JE; Stattin P Scand J Urol Nephrol; 2003; 37(3):210-2. PubMed ID: 12775278 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers. Leu M; Reilly M; Czene K J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865 [TBL] [Abstract][Full Text] [Related]
11. Prostate brachytherapy: a descriptive analysis from CaPSURE. Lee WR; Sharkey J; Cowan JE; DuChane J; Carroll PR; Brachytherapy; 2007; 6(2):123-8. PubMed ID: 17434105 [TBL] [Abstract][Full Text] [Related]
12. Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden. Bratt O; Berglund A; Adolfsson J; Johansson JE; Törnblom M; Stattin P; Scand J Urol Nephrol; 2010 Dec; 44(6):384-90. PubMed ID: 20624113 [TBL] [Abstract][Full Text] [Related]
13. Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer Registry. Stattin P; Johansson R; Damber JE; Hellström M; Hugosson J; Lundgren R; Varenhorst E; Johansson JE Scand J Urol Nephrol; 2003; 37(6):461-5. PubMed ID: 14675917 [TBL] [Abstract][Full Text] [Related]
14. Incidence of cancer among patients with atopic dermatitis. Hagströmer L; Ye W; Nyrén O; Emtestam L Arch Dermatol; 2005 Sep; 141(9):1123-7. PubMed ID: 16172309 [TBL] [Abstract][Full Text] [Related]
15. Age at diagnosis and age at death in familial prostate cancer. Brandt A; Bermejo JL; Sundquist J; Hemminki K Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895 [TBL] [Abstract][Full Text] [Related]
16. Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam. Roobol MJ; Grenabo A; Schröder FH; Hugosson J J Natl Cancer Inst; 2007 Sep; 99(17):1296-303. PubMed ID: 17728218 [TBL] [Abstract][Full Text] [Related]
17. Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Lindblad M; Ye W; Rubio C; Lagergren J Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2203-7. PubMed ID: 15598781 [TBL] [Abstract][Full Text] [Related]
18. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. Nieder AM; Porter MP; Soloway MS J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517 [TBL] [Abstract][Full Text] [Related]
19. Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer. Ellis WJ; Etzioni R; Vessella RL; Hu C; Goodman GE J Urol; 2001 Jul; 166(1):93-8; discussion 98-9. PubMed ID: 11435831 [TBL] [Abstract][Full Text] [Related]
20. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. Welch HG; Fisher ES; Gottlieb DJ; Barry MJ J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]